{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T00:19:24Z","timestamp":1787444364506,"version":"build-2736575974"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Butterfly glioblastomas (bGBM) are a rare subset of WHO grade IV tumours that carry a poor prognosis with a median survival ranging between 3.3 to 6\u00a0months. Given their poor prognosis, there is debate over whether histological diagnosis with a biopsy or any surgical or oncological intervention alters disease progression. With this in mind, we reviewed our experience as a high-volume unit to evaluate management decisions and outcomes. A retrospective analysis was undertaken (January 2009 to June 2021) of the electronic patient records of a large neurosurgical centre. We assessed patient demographics, initial clinical presentation, tumour characteristics, clinical management and overall survival (Kaplan\u2013Meier estimator, log-rank analysis and cox proportional hazard analysis). Eighty cases of bGBM were identified. These patients were managed with biopsy\u2009\u00b1\u2009adjuvant therapy (36), with radiotherapy alone without biopsy (3), or through surgical resection (3). Thirty-eight cases of suspected bGBM were managed conservatively, receiving no oncological treatment or surgical resection\/biopsy for histological diagnosis. Those managed conservatively and with radiotherapy without biopsy were diagnosed at neuro-oncology multidisciplinary meeting (MDT) based on clinical presentation and radiological imaging. No significant difference in survival was seen between conservative management compared with single adjuvant treatment (<jats:italic>p<\/jats:italic>\u2009=\u2009<jats:italic>0.69<\/jats:italic>). However, survival was significantly increased when patients received dual adjuvant chemoradiotherapy following biopsy or resection (<jats:italic>p<\/jats:italic>\u2009=\u2009<jats:italic>0.002<\/jats:italic>). A Cox Proportional Hazards model found that survival was significantly impacted by the oncology treatment (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), but was not significantly related to potential confounding variables such as the patient\u2019s age (<jats:italic>p<\/jats:italic>\u2009=\u20090.887) or KPS (<jats:italic>p<\/jats:italic>\u2009=\u20090.057). Butterfly glioblastoma have a poor prognosis. Our study would suggest that unless a patient is planned for adjuvant chemoradiotherapy following biopsy, they should be managed conservatively. This avoids unnecessary procedural interventions with the associated morbidities and costs.<\/jats:p>","DOI":"10.1007\/s10143-023-02126-w","type":"journal-article","created":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T07:02:43Z","timestamp":1693810963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Butterfly gliomas: a time for stratified management?"],"prefix":"10.1007","volume":"46","author":[{"given":"Siddharth","family":"Sinha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Avnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Perera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Pedro","family":"Lavrador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyoumars","family":"Ashkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,4]]},"reference":[{"key":"2126_CR1","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23:1231\u20131251","journal-title":"Neuro Oncol"},{"issue":"2","key":"2126_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s11060-013-1049-y","volume":"112","author":"K Kallenberg","year":"2013","unstructured":"Kallenberg K, Goldmann T, Menke J, Strik H, Bock HC, Stockhammer F, Buhk JH, Frahm J, Dechent P, Knauth M (2013) Glioma infiltration of the corpus callosum: early signs detected by DTI. J Neurooncol 112(2):217","journal-title":"J Neurooncol"},{"key":"2126_CR3","doi-asserted-by":"publisher","first-page":"e612","DOI":"10.1016\/j.wneu.2017.11.059","volume":"110","author":"M Opoku-Darko","year":"2018","unstructured":"Opoku-Darko M, Amuah JE, Kelly JJP (2018) Surgical resection of anterior and posterior butterfly glioblastoma. World neurosurgery 110:e612\u2013e620","journal-title":"World neurosurgery"},{"issue":"7","key":"2126_CR4","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1007\/s00701-021-04844-w","volume":"163","author":"A Boaro","year":"2021","unstructured":"Boaro A, Kavouridis VK, Siddi F, Mezzalira E, Harary M, Iorgulescu JB, Reardon DA, Smith TR (2021) Improved outcomes associated with maximal extent of resection for butterfly glioblastoma: insights from institutional and national data. Acta Neurochir 163(7):1883\u20131894","journal-title":"Acta Neurochir"},{"issue":"1","key":"2126_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-93441-z","volume":"11","author":"R Chojak","year":"2021","unstructured":"Chojak R, Ko\u017aba-Goszty\u0142a M, S\u0142ychan K, Gajos D, Kotas M, Tyliszczak M, Czapiga B (2021) Impact of surgical resection of butterfly glioblastoma on survival: a meta-analysis based on comparative studies. Sci Rep 11(1):1\u20137","journal-title":"Sci Rep"},{"issue":"3","key":"2126_CR6","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s11060-014-1597-9","volume":"120","author":"KL Chaichana","year":"2014","unstructured":"Chaichana KL, Jusue-Torres I, Lemos AM, Gokaslan A, Cabrera-Aldana EE, Ashary A, Olivi A, Quinones-Hinojosa A (2014) The butterfly effect on glioblastoma: is volumetric extent of resection more effective than biopsy for these tumors? J Neurooncol 120(3):625\u2013634","journal-title":"J Neurooncol"},{"key":"2126_CR7","doi-asserted-by":"publisher","first-page":"e156","DOI":"10.1016\/j.wneu.2020.08.053","volume":"144","author":"AM Jamshidi","year":"2020","unstructured":"Jamshidi AM, Eichberg DG, Komotar RJ, Ivan M (2020) Safety analysis of bilateral laser interstitial thermal therapy for treatment of butterfly glioma. World Neurosurg 144:e156\u2013e163","journal-title":"World Neurosurg"},{"issue":"10","key":"2126_CR8","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987\u2013996","journal-title":"N Engl J Med"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-023-02126-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-023-02126-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-023-02126-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T06:27:38Z","timestamp":1705904858000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-023-02126-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,4]]},"references-count":8,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2126"],"URL":"https:\/\/doi.org\/10.1007\/s10143-023-02126-w","relation":{},"ISSN":["1437-2320"],"issn-type":[{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,4]]},"assertion":[{"value":"26 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"223"}}